Mr. Robinson has 25 years professional experience in the pharmaceutical and biotech industry including 7 years with capital investments in the life science sector. He has held several leading international positions in AstraZeneca, Pfizer and Pronova Biopharma and several chairman and non-executive positions in smaller biotech companies. His experience covers a broad spectre in the pharmaceutical and biotech industry. This includes top management, marketing, sales, business development, licensing, regulatory affairs and broad experience in start-up and development of biotech companies from early nonclinical to clinical stages. He has extensive experience working with investors and investment banks including capital raising, private placements, mergers and IPOs. Mr. Robinson is the founder and CEO of Birk Venture and holds a M.Sc. from Norwegian School of Economics (NHH).